BRANDY MURRAY: Open Payments
NPI 1679027270 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,025 in 71 payments from 16 companies in 2025. Trend: 2023 $1,788 · 2024 $730 · 2025 $2,025
Food & beverage: $1,389Travel & lodging: $567Education: $68
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 13 | $1,041 |
| Ferring Pharmaceuticals Inc. | 8 | $165 |
| COLOPLAST CORP | 21 | $159 |
| Dendreon Pharmaceuticals LLC | 4 | $117 |
| Sumitomo Pharma America, Inc. | 5 | $83 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
| UROGEN PHARMA, INC. | 3 | $63 |
| ABBVIE INC. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $40 |
Products named: Axonics, ADSTILADRIN, Luja Coude, PROVENGE, GEMTESA, KEYTRUDA, IMFINZI, Xtandi.
Industry payments across SC — which companies pay providers there.
